Effect of reminder cards on compliance with antihypertensive medication

International Journal of Pharmacy Practice

Volumn 13, Issue 3, 2005, Pages 205-211

  Da Costa, Filipa Alves ^a   Guerreiro, José Pedro ^a   Nunes De Melo, Magda ^a   Da Costa Miranda, Ana ^a   Martins, Ana Paula ^a   Garção, José ^a   Madureira, Brenda ^a  

^a Centro de Estudos de Farmacoepidemiologia   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ALARM MONITORING; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT CARE; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACIST; PORTUGAL; PRIORITY JOURNAL; REMINDER SYSTEM; SELF REPORT;

EID: 25444464687     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.13.3.0006     Document Type: Article

References (44)

1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996;275:1571-6.
2. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62.
3. Gueyffier F, Froment A, Gouton M. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. J Hum Hypertens 1996;10:1-8.
4. Neaton JD, Grimm RH Jr, Prineas RJ et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993;270:713-24.
5. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
6. Drugs for hypertension. Med Lett Drugs Ther 1995;37:45-50.
7. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood-pressure control in the hypertensive population. Lancet 1997;349:454-7.
8. Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. Can Med Assoc J 1992;146:1997-2005.
9. Hershey JC, Morton BG, Davis JB, Reichgott MJ. Patient compliance with antihypertensive medication. Am J Public Health 1980;70:1081-9.
10. Bittar N. Maintaining long-term control of blood pressure: the role of improved compliance. Clin Cardiol 1995;18(6 Suppl 3):III-6.
11. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. Can Med Assoc J 1999;160:31-7.
12. Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ 1997;315:703-7.
13. Melnikow J, Kiefe C. Patient compliance and medical research: issues in methodology. J Gen Intern Med 1994;9:96-105.
14. Friedman RH, Kazis LE, Jette A et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996;9:285-92.
15. Haynes RB, Sackett DL, Gibson ES et al. Improvement of medication compliance in uncontrolled hypertension. Lancet 1976;1:1265-8.
16. Logan AG, Milne BJ, Achber C, Campbell WP, Haynes RB. Work-site treatment of hypertension by specially trained nurses. A controlled trial. Lancet 1979;2:1175-8.
17. Baird MG, Bentley-Taylor MM, Carruthers SG et al. A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group. Clin Invest Med 1984;7:95-102.
18. Gallefoss F, Bakke PS. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? Am J Respir Crit Care Med 1999;160:2000-5.
19. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 2002;22:1533-40.
20. Norell SE. Monitoring compliance with pilocarpine therapy. Am J Ophthalmol 1981;92:727-31.
21. Ley P. Improving communication, satisfaction and compliance. London: Croom Helm; 1988.
22. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
23. Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients' problems with new medication for chronic conditions. Qual Saf Health Care 2004;13:172-5.
24. Katon W, Rutter C, Ludman EJ et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry 2001;58:241-7.
25. National Heart LaBI. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Report No: 03-5233. Bethesda, US Department of Health and Human Services; 2003.
26. Martins AP, Melo MN, Mendes Z et al. Perfil Terapêutico da Hipertensäo na Rede de Médicos Sentinela. Revista Portuguesa de Clinica Geral 2001;17:359-72.
27. Guerrero D, Rudd P, Bryant-Kosling C, Middleton B, Middleton BF. Antihypertensive medication-taking. Investigation of a simple regimen. Am J Hypertens 1993;6:586-92.
28. Pullar T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets? Clin Pharmacol Ther 1989;46:163-8.
29. Peterson GM, McLean S, Millingen KS. A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia 1984;25:412-17.
30. Tuldra A, Fumaz CR, Ferrer MJ et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2000;25:221-8.
31. Thompson C, Peveler RC, Stephenson D, McKendrick J. Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant. Am J Psychiatry 2000;157:338-43.
32. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:757-64.
33. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002;288:2880-3.
34. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
35. Burnier M, Brunner HR. Antihypertensive treatment and compliance. Study was too short and lacked active intervention. BMJ 2001;323:1129.
36. Lee SS, Cheung PY, Chow MS. Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong. J Clin Pharmacol 2004;44:632-9.
37. Finley PR, Rens HR, Pont JT et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy 2003;23:1175-85.
38. Inui TS, Carter WB, Pecoraro RE, Pearlman RA, Dohan JJ. Variations in patient compliance with common long-term drugs. Med Care 1980;18:986-93.
39. Asplund J, Danielson M, Ohman P. Patients compliance in hypertension - the importance of number of tablets. Br J Clin Pharmacol 1984;17:547-52.
40. Faulkner MA, Wadibia EC, Lucas BD, Hilleman DE. Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy 2000;20:410-16.
41. Sanson-Fisher RW, Clover K. Compliance in the treatment of hypertension. A need for action. Am J Hypertens 1995;8:82S-88S.
42. Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 2001;323:142-6.
43. Sackett DL, Haynes RB, Gibson ES, Taylor DW, Roberts RS, Johnson AL. Patient compliance with antihypertensive regimens. Patient Couns Health Educ 1978;1:18-21.
44. Haynes RB, Gibson ES, Taylor DW, Bernholz CD, Sackett DL. Process versus outcome in hypertension: a positive result. Circulation 1982 Jan;65:28-33.